The strategic goal of shifting an individual’s physiological biomarkers, particularly hormones, from the lower end of the established population reference range toward the higher, yet still clinically safe, end of that range. This elevation aims to optimize subjective well-being and mitigate subclinical deficiencies rather than treating overt pathology. It reflects an application of functional endocrinology principles.
Origin
Combines the concept of “functionality” within the biological system with the deliberate raising (“elevation”) of measured values. This nomenclature separates proactive optimization from disease treatment paradigms.
Mechanism
Achieving this elevation typically involves enhancing the efficiency of the endocrine feedback loops or increasing precursor availability, thereby increasing the steady-state concentration of the target analyte. For example, improving nutrient uptake can support greater substrate availability for steroidogenesis, pushing the resultant hormone level higher within the normal distribution curve.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.